Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Praxis Precision Medicines, Inc. (PRAX) had Free Cash Flow per Share of $-8.48 for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-94.23M |
|
-- |
|
-- |
|
$106.91M |
|
$-106.91M |
|
$12.68M |
|
$-94.23M |
|
$-94.23M |
|
$-94.23M |
|
$-94.23M |
|
$-94.23M |
|
$-94.23M |
|
$-106.91M |
|
$-107.71M |
|
29.18M |
|
29.18M |
|
$-3.23 |
|
$-3.23 |
|
| Balance Sheet Financials | |
$762.80M |
|
$1.90M |
|
$549.27M |
|
$1.31B |
|
$52.50M |
|
-- |
|
-- |
|
$52.50M |
|
$1.26B |
|
$1.26B |
|
$1.26B |
|
27.95M |
|
| Cash Flow Statement Financials | |
$-245.43M |
|
$-365.39M |
|
$614.93M |
|
$357.75M |
|
$361.85M |
|
$4.11M |
|
$43.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-247.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.48% |
|
-7.48% |
|
-7.18% |
|
-7.48% |
|
$45.07 |
|
|
Free Cash Flow per Share |
$-8.48 |
$-8.41 |
|